Latest Articles
BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: July 9, 2025, 4:04 p.m.
Link between endometrial cancer and stress explored in pioneering new study at University of Brighton - V2 Radio
Link between endometrial cancer and stress explored in pioneering new study at University of Brighton V2 Radio
Published: July 9, 2025, 5:05 a.m.
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer - SussexWorld
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer SussexWorld
Published: July 8, 2025, 1:10 p.m.
Fertility Preservation and Assisted Reproductive Strategies in Endometrial Cancer Patients with Lynch Syndrome - Frontiers
Fertility Preservation and Assisted Reproductive Strategies in Endometrial Cancer Patients with Lynch Syndrome Frontiers
Published: July 7, 2025, 1:32 p.m.
‘Life as We Knew It’ Legend Dies of Endometrial Cancer: Susan Beth Pfeffer Was 77 - suggest.com
‘Life as We Knew It’ Legend Dies of Endometrial Cancer: Susan Beth Pfeffer Was 77 suggest.com
Published: July 4, 2025, 7:49 p.m.
AstraZeneca’s New Study on Endometrial Cancer: Key Insights for Investors - TipRanks
AstraZeneca’s New Study on Endometrial Cancer: Key Insights for Investors TipRanks
Published: July 4, 2025, 4:07 p.m.
Negative Findings Reported in ENGOT-EN1 Endometrial Cancer Study Led by Kristina Lindemann - Oncodaily
Negative Findings Reported in ENGOT-EN1 Endometrial Cancer Study Led by Kristina Lindemann Oncodaily
Published: July 4, 2025, 11:44 a.m.
Minimally Invasive Surgery With Sentinel Lymph Node Mapping in Elderly Patients With Early-Stage Endometrial Cancer: A Subgroup Analysis of a Prospective Cohort Study - Cureus
Minimally Invasive Surgery With Sentinel Lymph Node Mapping in Elderly Patients With Early-Stage Endometrial Cancer: A Subgroup Analysis of a Prospective Cohort Study Cureus
Published: July 3, 2025, 5:42 a.m.
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications - TipRanks
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications TipRanks
Published: July 2, 2025, 5:03 p.m.
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country - Express Pharma
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Express Pharma
Published: July 2, 2025, 7 a.m.
Link copied to clipboard!